Specific induction of migration and invasion of pancreatic carcinoma cells by RhoC, which differs from RhoA in its localisation and activity

Biological Chemistry

Volumn 390, Issue 10, 2009, Pages 1063-1077

  Dietrich, Karin Almut ^a,c   Schwarz, Rene ^a   Liska, Martina ^a   Graß, Stefanie ^a   Menke, Andre ^a   Meister, Michael ^a,b   Kierschke, Gesa ^a   Längle, Claudia ^a   Genze, Felicitas ^a   Giehl, Klaudia ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Dbs; GTP binding; Invasion; Migration; RhoC; SopE

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANOSINE DIPHOSPHATE; GUANOSINE TRIPHOSPHATE; INHIBITOR PROTEIN; MESSENGER RNA; RHO GDP DISSOCIATION INHIBITOR ALPHA; RHO GDP DISSOCIATION INHIBITOR BETA; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; RHOC GUANINE NUCLEOTIDE BINDING PROTEIN; SERUM RESPONSE FACTOR; UNCLASSIFIED DRUG;

ADVANCED CANCER; ARTICLE; CANCER INVASION; CARCINOMA CELL; CELL INVASION; CELL MEMBRANE; CELL MIGRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

CELL LINE, TUMOR; CELL MOVEMENT; DEEP BRAIN STIMULATION; HUMANS; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; PROTEIN ISOFORMS; RAP GTP-BINDING PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHO GTP-BINDING PROTEINS; RHOA GTP-BINDING PROTEIN; RNA, MESSENGER;

EID: 70349305426     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2009.110     Document Type: Article

References (61)

1. Arthur, W.T., Ellerbroek, S.M., Der, C.J., Burridge, K., and Wen-nerberg, K. (2002). XPLN, a guanine nucleotide exchange factor for RhoA and RhoB, but not RhoC. J. Biol. Chem. 277, 42964-42972.
2. Bernards, A. (2003). GAPs galore! A survey of putative Ras superfamily GTPase activating proteins in man and Drosoph-ila. Biochim. Biophys. Acta 1603, 47-82.
3. Buchwald, G., Friebel, A., Galan, J.E., Hardt, W.D., Wittinghofer, A., and Scheffzek, K. (2002). Structural basis for the reversible activation of a Rho protein by the bacterial toxin SopE. EMBO J. 21, 3286-3295.
4. Burstein, E.S. and Macara, I.G. (1992). Interactions of the ras-like protein p25rab3A with Mg2q and guanine nucleotides. Biochem. J. 282, 387-392.
5. Clark, E.A., Golub, T.R., Lander, E.S., and Hynes, R.O. (2000). Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406, 532-535.
6. DeBlasi, A., O'Reilly, K., and Motulsky, H.J. (1989). Calculating receptor number from binding experiments using same compound as radioligand and competitor. Trends Pharmacol. Sci. 10, 227-229.
7. Dermardirossian, C. and Bokoch, G.M. (2005). GDIs: central regulatory molecules in Rho GTPase activation. Trends Cell Biol. 15, 356-363.
8. Dias, S.M. and Cerione, R.A. (2007). X-Ray crystal structures reveal two activated states for RhoC. Biochemistry 46, 6547-6558.
9. Dreissigacker, U., Mueller, M.S., Unger, M., Siegert, P., Genze, F., Gierschik, P., and Giehl, K. (2006). Oncogenic K-Ras down-regulates Rac1 and RhoA activity and enhances migration and invasion of pancreatic carcinoma cells through activation of p38. Cell Signal. 18, 1156-1168.
10. Elsasser, H.P., Lehr, U., Agricola, B., and Kern, H.F. (1992). Establishment and characterisation of two cell lines with different grade of differentiation derived from one primary human pancreatic adenocarcinoma. Virchow's Arch. B Cell Pathol. Incl. Mol. Pathol. 61, 295-306.
11. Etienne-Manneville, S. and Hall, A. (2002). Rho GTPases in cell biology. Nature 420, 629-635.
12. Evelyn, C.R., Wade, S.M., Wang, Q., Wu, M., Iniguez-Lluhi, J.A., Merajver, S.D., and Neubig, R.R. (2007). CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling. Mol. Cancer Ther. 6, 2249-2260.
13. Feig, L.A. (1999). Tools of the trade: use of dominant-inhibitory mutants of Ras-family GTPases. Nat. Cell Biol. 1, E25-E27.
14. Fensterer, H., Giehl, K., Buchholz, M., Ellenrieder, V., Buck, A., Kestler, H.A., Adler, G., Gierschik, P., and Gress, T.M. (2004). Expression profiling of the influence of RAS mutants on the TGFB1-induced phenotype of the pancreatic cancer cell line PANC-1. Genes Chromosomes Cancer 39, 224-235.
15. Friebel, A., Ilchmann, H., Aepfelbacher, M., Ehrbar, K., Machleidt, W., and Hardt, W.D. (2001). SopE and SopE2 from Salmonella typhimurium activate different sets of Rho GTPases of the host cell. J. Biol. Chem. 276, 34035-34040.
16. Geneste, O., Copeland, J.W., and Treisman, R. (2002). LIM kinase and Diaphanous cooperate to regulate serum response factor and actin dynamics. J. Cell Biol. 157, 831-838.
17. Gineitis, D. and Treisman, R. (2001). Differential usage of signal transduction pathways defines two types of serum response factor target gene. J. Biol. Chem. 276, 24531-24539.
18. Haeusler, L.C., Blumenstein, L., Stege, P., Dvorsky, R., and Ahmadian, M.R. (2003). Comparative functional analysis of the Rac GTPases. FEBS Lett. 555, 556-560.
19. Hakem, A., Sanchez-Sweatman, O., You-Ten, A., Duncan, G., Wakeham, A., Khokha, R., and Mak, T.W. (2005). RhoC is dispensable for embryogenesis and tumour initiation but essential for metastasis. Genes Dev. 19, 1974-1979.
20. Hall, C.L., Dubyk, C.W., Riesenberger, T.A., Shein, D., Keller, E.T., and van Golen, K.L. (2008). Type I collagen receptor (a2b1) signaling promotes prostate cancer invasion through RhoC GTPase. Neoplasia 10, 797-803.
21. Hardt, W.D., Chen, L.M., Schuebel, K.E., Bustelo, X.R., and Galan, J.E. (1998). S. typhimurium encodes an activator of Rho GTPases that induces membrane ruffling and nuclear responses in host cells. Cell 93, 815-826.
22. Hemsath, L. and Ahmadian, M.R. (2005). Fluorescence approaches for monitoring interactions of Rho GTPases with nucleotides, regulators, and effectors. Methods 37, 173-182.
23. Hill, C.S., Wynne, J., and Treisman, R. (1995). The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF. Cell 81, 1159-1170.
24. Hofer, M.D., Menke, A., Genze, F., Gierschik, P., and Giehl, K. (2004). Expression of MTA1 promotes motility and invasive-ness of PANC-1 pancreatic carcinoma cells. Br. J. Cancer 90, 455-462.
25. Iiizumi, M., Bandyopadhyay, S., Pai, S.K., Watabe, M., Hirota, S., Hosobe, S., Tsukada, T., Miura, K., Saito, K., Furuta, E., et al. (2008). RhoC promotes metastasis via activation of the Pyk2 pathway in prostate cancer. Cancer Res. 68, 7613-7620.
26. Illenberger, D., Schwald, F., Pimmer, D., Binder, W., Maier, G., Dietrich, A., and Gierschik, P. (1998). Stimulation of phos-pholipase C-b2 by the Rho GTPases Cdc42Hs and Rac1. EMBO J. 17, 6241-6249.
27. Imamichi, Y., Waidmann, O., Hein, R., Eleftheriou, P., Giehl, K., and Menke, A. (2005). TGFb-induced focal complex formation in epithelial cells is mediated by activated ERK and JNK MAP kinases and is independent of Smad4. Biol. Chem. 386, 225-236.
28. Itoh, R.E., Kurokawa, K., Ohba, Y., Yoshizaki, H., Mochizuki, N., and Matsuda, M. (2002). Activation of rac and cdc42 video imaged by fluorescent resonance energy transfer-based single-molecule probes in the membrane of living cells. Mol. Cell. Biol. 22, 6582-6591.
29. Jaffe, A.B. and Hall, A. (2005). Rho GTPases: biochemistry and biology. Annu. Rev. Cell Dev. Biol. 21, 247-269.
30. John, J., Rensland, H., Schlichting, I., Vetter, I., Borasio, G.D., Goody, R.S., and Wittinghofer, A. (1993). Kinetic and structural analysis of the Mg2q-binding site of the guanine nucle-otide-binding protein p21H-ras. J. Biol. Chem. 268, 923-929.
31. Kabcenell, A.K., Goud, B., Northup, J.K., and Novick, P.J. (1990). Binding and hydrolysis of guanine nucleotides by Sec4p, a yeast protein involved in the regulation of vesicular traffic. J. Biol. Chem. 265, 9366-9372.
32. Lin, R., Bagrodia, S., Cerione, R., and Manor, D. (1997). A novel Cdc42Hs mutant induces cellular transformation. Curr. Biol. 7, 794-797.
33. Mao, J., Yuan, H., Xie, W., and Wu, D. (1998). Guanine nucleo-tide exchange factor GEF115 specifically mediates activation of Rho and serum response factor by the G protein a subunit Ga13. Proc. Natl. Acad. Sci. USA 95, 12973-12976.
34. Mukai, M., Endo, H., Iwasaki, T., Tatsuta, M., Togawa, A., Naka-mura, H., and Inoue, M. (2006). RhoC is essential for TGF-b1-induced invasive capacity of rat ascites hepatoma cells. Biochem. Biophys. Res. Commun. 346, 74-82.
35. Philippar, U., Schratt, G., Dieterich, C., Muller, J.M., Galgoczy, P., Engel, F.B., Keating, M.T., Gertler, F., Schule, R., Vingron, M., et al. (2004). The SRF target gene Fhl2 antagonizes RhoA/MAL-dependent activation of SRF. Mol. Cell 16, 867-880.
36. Pille, J.Y., Denoyelle, C., Varet, J., Bertrand, J.R., Soria, J., Opo-lon, P., Lu, H., Pritchard, L.L., Vannier, J.P., Malvy, C., et al. (2005). Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo. Mol. Ther. 11, 267-274.
37. Pipes, G.C., Creemers, E.E., and Olson, E.N. (2006). The myo-cardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesis. Genes Dev. 20, 1545-1556.
38. Ridley, A.J. (2004). Rho proteins and cancer. Breast Cancer Res. Treat. 84, 13-19.
39. Rossman, K.L., Der, C.J., and Sondek, J. (2005). GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat. Rev. Mol. Cell Biol. 6, 167-180.
40. Sahai, E. and Marshall, C.J. (2002a). ROCK and Dia have opposing effects on adherens junctions downstream of Rho. Nat. Cell Biol. 4, 408-415.
41. Sahai, E. and Marshall, C.J. (2002b). Rho-GTPases and cancer. Nat. Rev. Cancer 2, 133-142.
42. Schlumberger, M.C., Friebel, A., Buchwald, G., Scheffzek, K., Wittinghofer, A., and Hardt, W.D. (2003). Amino acids of the bacterial toxin SopE involved in G nucleotide exchange on Cdc42. J. Biol. Chem. 278, 27149-27159.
43. Schmidt, A. and Hall, A. (2002). Guanine nucleotide exchange factors for Rho GTPases: turning on the switch. Genes Dev. 16, 1587-1609.
44. Schnelzer, A., Prechtel, D., Knaus, U., Dehne, K., Gerhard, M., Graeff, H., Harbeck, N., Schmitt, M., and Lengyel, E. (2000). Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b. Oncogene 19, 3013-3020.
45. Self, A.J. and Hall, A. (1995a). Measurement of intrinsic nucle-otide exchange and GTP hydrolysis rates. Methods Enzymol. 256, 67-76.
46. Self, A.J. and Hall, A. (1995b). Purification of recombinant Rho/ Rac/G25K from Escherichia coli. Methods Enzymol. 256, 3-10.
47. Simpson, K.J., Dugan, A.S., and Mercurio, A.M. (2004). Functional analysis of the contribution of RhoA and RhoC GTPases to invasive breast carcinoma. Cancer Res. 64, 8694-8701.
48. Snyder, J.T., Worthylake, D.K., Rossman, K.L., Betts, L., Pruitt, W.M., Siderovski, D.P., Der, C.J., and Sondek, J. (2002). Structural basis for the selective activation of Rho GTPases by Dbl exchange factors. Nat. Struct. Biol. 9, 468-475.
49. Sobin, L.H. and Wittekind, C. (2002). TNM Classification of malignant tumours: Pancreas. In: TNM Classification of Malignant Tumours, 6th edn. (Geneva, Switzerland: UICC International Union against Cancer), pp. 93-96
50. Stähle, M., Veit, C., Bachfischer, U., Schierling, K., Skripczynski, B., Hall, A., Gierschik, P., and Giehl, K. (2003). Mechanisms in LPA-induced tumour cell migration: critical role of phos-phorylated ERK. J. Cell Sci. 116, 3835-3846.
51. Stender, S., Friebel, A., Linder, S., Rohde, M., Mirold, S., and Hardt, W.D. (2000). Identification of SopE2 from Salmonella typhimurium, a conserved guanine nucleotide exchange factor for Cdc42 of the host cell. Mol. Microbiol. 36, 1206-1221.
52. Suwa, H., Ohshio, G., Imamura, T., Watanabe, G., Arii, S., Ima-mura, M., Narumiya, S., Hiai, H., and Fukumoto, M. (1998). Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas. Br. J. Cancer 77, 147-152.
53. van Golen, K.L., Wu, Z.F., Qiao, X.T., Bao, L., and Merajver, S.D. (2000). RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells. Neoplasia 2, 418-425.
54. Veit, C., Genze, F., Menke, A., Hoeffert, S., Gress, T.M., Giers-chik, P., and Giehl, K. (2004). Activation of phosphatidylino-sitol 3-kinase and extracellular signal-regulated kinase is required for glial cell line-derived neurotrophic factor-induced migration and invasion of pancreatic carcinoma cells. Cancer Res. 64, 5291-5300.
55. Villalonga, P. and Ridley, A.J. (2006). Rho GTPases and cell cycle control. Growth Factors 24, 159-164.
56. Wang, W., Wu, F., Fang, F., Tao, Y., and Yang, L. (2008). RhoC is essential for angiogenesis induced by hepatocellular carcinoma cells via regulation of endothelial cell organization. Cancer Sci. 99, 2012-2018.
57. Wheeler, A.P. and Ridley, A.J. (2004). Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility. Exp. Cell Res. 301, 43-49.
58. Wu, M., Wu, Z.F., Kumar-Sinha, C., Chinnaiyan, A., and Merajver, S.D. (2004). RhoC induces differential expression of genes involved in invasion and metastasis in MCF10A breast cells. Breast Cancer Res. Treat. 84, 3-12.
59. Wu, M., Wu, Z.F., and Merajver, S.D. (2007). Rho proteins and cell-matrix interactions in cancer. Cells Tissues Organs 185, 100-103.
60. Zhang, B., Zhang, Y., Wang, Z., and Zheng, Y. (2000). The role of Mg2q cofactor in the guanine nucleotide exchange and GTP hydrolysis reactions of Rho family GTP-binding proteins. J. Biol. Chem. 275, 25299-25307. (Pubitemid 30687026)
61. Zheng, Y., Glaven, J.A., Wu, W.J., and Cerione, R.A. (1996). Phosphatidylinositol 4,5-bisphosphate provides an alternative to guanine nucleotide exchange factors by stimulating the dissociation of GDP from Cdc42Hs. J. Biol. Chem. 271, 23815-23819.